ARTICLE | Company News
Management tracks: Sotio, EpimAb
February 27, 2018 10:33 PM UTC
Cancer and autoimmune disease company Sotio a.s. (Prague, Czech Republic) said CEO Ladislav Bartonícek will transition to the company's board, effective March 1. He is succeeded by CSO and Co-founder Radek Spíšek.
Bi-specific antibody company EpimAb Biotherapeutics Inc. (Shanghai, China) hired Bin Peng as CMO. He was global head of oncology translational medicine, China at Novartis AG (NYSE:NVS; SIX:NOVN)...